you are viewing a single comment's thread.
The old Barrons bounce for one.Nice article by Mike Santoli never hurts. Rich
Thanks - I saw that. It seemed to be too general stating how ABT had few patents expiring and they were diversified. But, any good press helps. Given this recent rise in price, I'm wondering if there is something in the works. Us little guys are always the last to know.
I would strongly suggest you go look at the latest 10-Q and see the magnitude of the revenue that will be lost when Humira patent expiresit is not "just a couple of bucks"it is HUGE
chart excellent on april 15
Marvin Gaye asked the same question, then his old man put a round in his head. EOM